Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, Circular RNAs in diseases, Ubiquitin and proteasome pathways, and MicroRNA in disease regulation.
Stereoscopic Quantitative Analysis of Enteric Nervous System in Patients With Slow Transit Constipation
Pathological and immune features of non-tuberculous mycobacteria and Mycobacterium tuberculosis cutaneous/mucosa infections of fifty-four biopsies
Pathological and immune features of non-tuberculous mycobacteria and <i>Mycobacterium tuberculosis</i> cutaneous/mucosa infections of fifty-four biopsies.
Crystal-storing histiocytosis of multiple myeloma with a novel multi-exon deletion of WRN: A case report and mini review of literature.
HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial
Salvianolic acid B attenuates inflammation and prevent pathologic fibrosis by inhibiting CD36-mediated activation of the PI3K-Akt signaling pathway in frozen shoulder
De-ubiquitination of SAMHD1 by USP7 promotes DNA damage repair to overcome oncogenic stress and affect chemotherapy sensitivity
Abstract P4-01-07: FS-1502, an anti-HER2 ADC, in Patients with HER2-Expressing Advanced Solid Tumors: A Phase 1a Dose-Escalation Study
FS-1502 in <i>HER2</i>-positive advanced breast cancer: Results from an open-label, phase 1 study.
<i>LCDR</i> regulates the integrity of lysosomal membrane by hnRNP K–stabilized <i>LAPTM5</i> transcript and promotes cell survival
A Cross-Sectional Study of the Distribution Patterns and Potential Determinants in Plasma Selenium Status Among Chinese Adults With Hypertension
The deacetylation-phosphorylation regulation of SIRT2-SMC1A axis as a mechanism of antimitotic catastrophe in early tumorigenesis
Plasma selenium and the risk of first stroke in adults with hypertension: a secondary analysis of the China Stroke Primary Prevention Trial
Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma
Vitamin D deficiency exacerbates Alzheimer-like pathologies by reducing antioxidant capacity
High mobility group box 2 modulates the progression of osteosarcoma and is related with poor prognosis.
EFEMP1 as a Potential Biomarker for Diagnosis and Prognosis of Osteosarcoma.
Fibulin-3 affects vascular endothelial function and is regulated by angiotensin II.
Lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activation
Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma.
CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9
Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib‐resistant lung adenocarcinoma cells
AEG-1 associates with metastasis in papillary thyroid cancer through upregulation of MMP2/9
The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer
EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway
The prognostic value of tumor budding in invasive breast cancer